Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Type II diabetes mellitus | R-HSA-2127377 | map04930 | nadide | 5959 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | nadide | 5959 | drug-path |
Small cell lung cancer | R-HSA-5619066 | map05222 | nadide | 5959 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | nadide | 5959 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | nadide | 5959 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | nadide | 5959 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | nadide | 5959 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | nadide | 5959 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | nadide | 5959 | drug-path |
Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | nadide | 5959 | drug-path |
mTOR signaling pathway | R-HSA-165662 | map04150 | nadide | 5959 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | nadide | 5959 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | nadide | 5959 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | nadide | 5959 | drug-path |
Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | phenoxybenzamine | 4768 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | phenoxybenzamine | 4768 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | phenoxybenzamine | 4768 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | phenoxybenzamine | 4768 | drug-path |
Axon guidance | R-HSA-422475 | map04360 | phenoxybenzamine | 4768 | drug-path |
Bladder cancer | R-HSA-9700206 | map05219 | phenoxybenzamine | 4768 | drug-path |